| ADC | antibody–drug conjugate |
| ADP | poly-adenosine diphosphate |
| AI | aromatase inhibitor |
| AON | antisense oligonucleotide |
| APCL | adenomatous polyposis coli protein-like gene |
| AR | androgen receptor |
| ATM | ataxia telangiectasia mutated gene |
| ATRA | all-trans retinoic acid |
| BCSC | breast cancer stem cell |
| BRCA1 | breast cancer susceptibility gene 1 |
| BRCA2 | breast cancer susceptibility gene 2 |
| CAR-T | chimeric antigen receptor (CAR) T-cell |
| CSA | Cockayne syndrome group A |
| CSC | cancer stem cell |
| CTLA-4 | cytotoxic T-lymphocyte-associated antigen 4 |
| DEAB | diethylamino benzaldehyde |
| DHEAS | dehydroepiandrosterone sulfate |
| DHT | 5α-dihydrotestosterone |
| DLL-1 | Delta-like-1 |
| DLL-3 | Delta-like-3 |
| DLL-4 | Delta-like-4 |
| EGF | epidermal growth factor |
| EGFR | epidermal growth factor receptor |
| EMA | European Medicine Agency |
| EMT | epithelial-to-mesenchymal transition |
| ER | estrogen receptor |
| ER− | ER-negative |
| ER+ | ER-positive |
| ESR1 | estrogen receptor gene |
| FDA | The United States Food and Drug Administration |
| GFR | growth factor receptor |
| GSI | γ-secretase inhibitor |
| HDACi | histone deacetylase inhibitor |
| HDAC | histone deacetylase |
| HER2 | human epidermal growth factor receptor 2 |
| HER2− | HER2-negative |
| HER2+ | HER2-positive |
| Hh | Hedgehog |
| HR | hormone receptor |
| HR+ | HR-positive |
| ICI | immune checkpoint inhibitor |
| iDFS | invasive disease-free survival |
| IL-6 | cytokine interleukin-6 |
| InsR | insulin receptor |
| JAK | Janus kinase |
| mBC | advanced or metastatic breast cancer |
| MMP | matrix metalloproteinase |
| mTOR | mammalian target of rapamycin |
| N/A | not applicable |
| NRARP | Notch-regulated ankyrin repeat protein |
| OS | overall survival |
| p110 | the catalytic subunit of PI3K |
| p85 | the regulatory subunit of PI3K |
| PARP | poly-adenosine diphosphate-ribose polymerase |
| PD-1 | programmed cell death-1 |
| PD-L1 | programmed cell death ligand-1 |
| PFS | progression-free survival |
| PI3K | phosphoinositide 3 kinase |
| PR | progesterone receptor |
| pRB | retinoblastoma protein |
| RB | retinoblastoma |
| RTK | growth factor receptor tyrosine kinase |
| SFK | Src family kinase |
| STAT | signal transducers and activators of transcription |
| TNBC | triple-negative breast cancer |
| TROP-2 | trophoblast cell-surface antigen 2 |
| ZIP9 | iron-regulated transporter-like protein 9 |